Brett A Pletcher Form 3 GILEAD SCIENCES / Brett A Pletcher ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Pletcher Brett A

(Last) (First) (Middle)

333 LAKESIDE DRIVE

(Street)

FOSTER CITY CA 94404

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/09/2018

3. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES INC [ GILD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
EVP, Gen Counsel & Corp Sec

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	18,941	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified Stock Option (Right to Buy)	(1)	07/29/2019	Common Stock	7,200	24.905	D
Non-qualified Stock Option (Right to Buy)	(1)	07/22/2020	Common Stock	2,400	16.89	D
Non-qualified Stock Option (Right to Buy)	(2)	01/26/2022	Common Stock	35,400	24.295	D
Non-qualified Stock Option (Right to Buy)	(2)	02/01/2023	Common Stock	32,560	40.56	D
Non-qualified Stock Option (Right to Buy)	(2)	02/01/2024	Common Stock	25,780	80.65	D
Non-qualified Stock Option (Right to Buy)	(2)	02/01/2025	Common Stock	23,460	104.83	D
Non-qualified Stock Option (Right to Buy)	(2)	08/10/2025	Common Stock	14,830	116.58	D
Non-qualified Stock Option (Right to Buy)	(2)	02/01/2026	Common Stock	53,590	84.05	D
Non-qualified Stock Option (Right to Buy)	(2)	02/02/2027	Common Stock	73,480	72.25	D
Non-qualified Stock Option (Right to Buy)	(2)	02/01/2028	Common Stock	69,200	83.49	D
Restricted Stock Unit	(3)	(3)	Common Stock	4,140	(4)	D

Explanation of Responses:

1. The shares subject to the option have a five-year vesting schedule. 20% vest on the first anniversary of the date of the grant. The balance will vest 5% quarterly thereafter until fully vested.

2. The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

3. The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.

4. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

	/s/ Brett A. Pletcher	05/16/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.